Talk about a surprise perk. Numerous additional benefits of GLP-1 weight loss drugs like Ozempic continue to be discovered, from improving...

Talk about a surprise perk. Numerous additional benefits of GLP-1 weight loss drugs like Ozempic continue to be discovered, from improving...

Potentially giving it an early start in a key market after Novo Nordisk A/S’s Ozempic patent expired. ......

Potentially giving it an early start in a key market after Novo Nordisk A/S’s Ozempic patent expired. ......

With the U.S. Food and Drug Administration (FDA) recently approving GLP-1 drug Wegovy in pill form for use in weight loss and fighting obesity, the...

With the U.S. Food and Drug Administration (FDA) recently approving GLP-1 drug Wegovy in pill form for use in weight loss and fighting obesity, the...

Scientists are developing a futuristic approach to treating diabetes that sounds like science fiction but may one day become reality. Researchers at...

This is the first positive Phase 3 trial of a HIF-2 alpha inhibitor in combination with a multi-targeted tyrosine kinase inhibitor, the first for...

This is the first positive Phase 3 trial of a HIF-2 alpha inhibitor in combination with a multi-targeted tyrosine kinase inhibitor, the first for...

UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo Nordisk...